Hospital-associated Clostridium difficile infection: Is it necessary to track community-onset disease?

Infection Control and Hospital Epidemiology

Volumn 30, Issue 4, 2009, Pages 332-337

  Dubberke, Erik R ^a   McMullen, Kathleen M ^b   Mayfield, Jennie L ^b   Reske, Kimberly A ^a   Georgantopoulos, Peter ^a   Warren, David K ^a   Fraser, Victoria J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PIPERACILLIN PLUS TAZOBACTAM; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DATA COLLECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SENTINEL SURVEILLANCE; TIME FACTORS; YOUNG ADULT;

EID: 63449130403     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/596604     Document Type: Article

References (14)

1. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-145.
2. Kutty PK, Benoit SR, Woods CW, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008; 29:197-202.
3. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 2007; 13:1058-1064.
4. Price MF, Dao-Tran T, Garey KW, et al. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 2007; 65:42-46.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
6. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-619.
7. The Association for Professionals in Infection Control and Epidemiology, Inc. National Prevalence Study of Clostridium difficile in U.S. Healthcare Facilities. Available at: http://www.apic.org/AM/CM/ContentDisplay .cfm?ContentFileID = 11410. Accessed November 17, 2008.
8. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45:1543-1549.
9. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med 2007; 167:1092-1097.
10. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166: 561-567.
11. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210.
12. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16:459-477.
13. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002; 23:696-703.
14. Wong ES, Rupp ME, Mermel L, et al. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 2005; 26:210-212.